Literature DB >> 12691574

Thorium(IV) complexes of bidentate hydroxypyridinonates.

Jide Xu1, Donald W Whisenhunt, Alan C Veeck, Linda C Uhlir, Kenneth N Raymond.   

Abstract

The coordination chemistry of actinide(IV) ions with hydroxypyridinone ligands has been initially explored by examining the complexation of Th(IV) ion with bidentate PR-1,2-HOPO (HL(1)()), PR-Me-3,2-HOPO (HL(2)()), and PR-3,4-HOPO-N (HL(3)()) ligands. The complexes Th(L(1)())(4), Th(L(2)())(4), and Th(L(3)())(4) were prepared in methanol solution from Th(acac)(4) and the corresponding ligand. Single-crystal X-ray diffraction analyses are reported for the free ligand PR-Me-3,2-HOPO (HL(2)()) [Ponemacr;, Z = 8, a = 8.1492(7) A, b = 11.1260(9) A, c = 23.402(2) A, alpha = 87.569(1) degrees, beta = 86.592(1) degrees, gamma = 87.480(1) degrees ], and the complex Th(L(2)())(4).H(2)O [Pna2(1) (No. 33), Z = 4, a = 17.1250(5) A, b = 12.3036(7) A, c = 23.880 (1) A]. A comparison of the structure of the metal complex Th-PR-Me-3,2-HOPO with that of free ligand PR-Me-3,2-HOPO reveals that the ligand geometry is the same in the free ligand and in the metal complex. Amide hydrogen bonds enhance the rigidity and stability of the complex and demonstrate that the Me-3,2-HOPO ligands are predisposed for metal chelation. Solution thermodynamic studies determined overall formation constants (log beta(140)) for Th(L(1)())(4), Th(L(2)())(4), and Th(L(3)())(4) of 36.0(3), 38.3(3), and 41.8(5), respectively. Species distribution calculations show that the 4:1 metal complex Th(L)(4) is the dominant species in the acidic range (pH < 6) for PR-1,2-HOPO, in weakly acidic to physiological pH range for PR-Me-3,2-HOPO and in the high-pH range (>8) for PR-3,4-HOPO-N. This finding parallels the relative acidity of these structurally related ligands. In the crystal of [Th(L(2)())(4)].H(2)O, the chiral complex forms an unusual linear coordination polymer composed of linked, alternating enantiomers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691574     DOI: 10.1021/ic0259888

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  6 in total

1.  Investigation of the complexation of natZr(iv) and 89Zr(iv) by hydroxypyridinones for the development of chelators for PET imaging applications.

Authors:  F Guérard; M Beyler; Y-S Lee; R Tripier; J-F Gestin; M W Brechbiel
Journal:  Dalton Trans       Date:  2017-04-05       Impact factor: 4.390

2.  New Synthetic Approach for the Incorporation of 3,2-Hydroxypyridinone (HOPO) Ligands: Synthesis of Structurally Diverse Poly HOPO Chelators.

Authors:  Jayanthi Arumugam; Hayley A Brown; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Synthesis (Stuttg)       Date:  2011-01-01       Impact factor: 3.157

3.  New methodology for the preparation of 3-hydroxy-2-pyridinone (3,2-HOPO) chelators and extractants. Part 2. Reactions of alcohols, phenols, and thiols with an electrophilic 3,2-HOPO reagent().

Authors:  Sumathi Chittamuru; Timothy N Lambert; Gloria Martinez; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2007-01-20       Impact factor: 2.415

4.  3,2-Hydroxypyridinone (3,2-HOPO) vinyl sulfonamide and acrylamide linkers: Aza-Michael addition reactions and the preparation of poly-HOPO chelators.

Authors:  Gloria Martinez; Jayanthi Arumugam; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2013-02-13       Impact factor: 2.415

5.  Improved deposition and deprotection of silane tethered 3,4 hydroxypyridinone (HOPO) ligands on functionalized nanoporous silica.

Authors:  Joseph D Davidson; Robert J Wiacek; Sarah Burton; Xiaohong S Li; Glen E Fryxell; R Shane Addleman; Wassana Yantasee; Thanapon Sangvanich; Kanda Pattamakomsan
Journal:  Inorg Chem Commun       Date:  2012-04       Impact factor: 2.495

6.  A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo.

Authors:  Xiaomei Wang; Xing Dai; Cen Shi; Jianmei Wan; Mark A Silver; Linjuan Zhang; Lanhua Chen; Xuan Yi; Bizheng Chen; Duo Zhang; Kai Yang; Juan Diwu; Jianqiang Wang; Yujie Xu; Ruhong Zhou; Zhifang Chai; Shuao Wang
Journal:  Nat Commun       Date:  2019-06-25       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.